Senseonics Holdings Inc. Common Stock (SENS)

FairStock Score: 31/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Senseonics as a Graham-style analyst: what is the business worth, and what evidence supports it? Senseonics sells implantable continuous glucose monitoring systems. Revenue is moving: in fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $14.5 million, up from $6.6 million in fiscal Q2 2025, the quarter ended 2025-06-30. Full-year fiscal 2025 revenue was $35.3 million. But the company is losing money heavily. Fiscal Q2 2026 net income was -$36.7 million, with diluted EPS of -$0.63. Fiscal 2025 net income was -$69.1 million, or -$1.66 per diluted share. Trailing free cash flow is -$96.8 million, a -20.5% FCF yield on the $471.6 million market cap. FairStock's calculations show a P/B of 5.22, ROE of -118.24%, ROCE of -41.41%, debt-to-equity of 0.70, Piotroski F-Score 4/9, and Altman Z-Score -4.96, which points to financial fragility. The stock at $8.92 on 2026-10-13 sits in a 52-week range of $4.79 to $10.64. The Lynch category is TURNAROUND because of a loss in the latest year after earlier profits, but I demand a balance-sheet cushion and a path to positive cash generation before calling any turnaround real. Revenue growth is encouraging, but losses are widening and cash is leaving the business. Without profits, the valuation rests on hope, not on demonstrated earning power. I would watch whether revenue growth eventually outpaces cash burn and whether the capital structure can support the company long enough to prove itself.

In plain English: Senseonics makes implantable glucose sensors for people with diabetes. Sales are rising quickly, but the company still loses a lot of money and burns cash. At $8.92 a share, the market values it at $471.6 million, and with no profits and heavy cash use, the price looks expensive against its current numbers.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer